RELX (RELX)
(Delayed Data from NYSE)
$43.46 USD
+0.08 (0.18%)
Updated May 10, 2024 04:00 PM ET
After-Market: $43.48 +0.02 (0.05%) 7:58 PM ET
4-Sell of 5 4
D Value B Growth D Momentum C VGM
Price, Consensus and EPS Surprise
RELX 43.46 +0.08(0.18%)
Will RELX be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for RELX based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for RELX
RELX's LexisNexis Risk Solutions Adds Feature to Its Platform
TME or RELX: Which Is the Better Value Stock Right Now?
RELX: What are Zacks experts saying now?
Zacks Private Portfolio Services
What Makes RELX PLC (RELX) a Strong Momentum Stock: Buy Now?
PERI or RELX: Which Is the Better Value Stock Right Now?
TME vs. RELX: Which Stock Is the Better Value Option?
Other News for RELX
GLOBAL BROKER RATINGS: UBS raises Leonardo; Berenberg cuts Symrise
Relx initiated with neutral view at Deutsche Bank, here's why
LONDON BROKER RATINGS: UBS raises Trainline, cuts Kingspan
LexisNexis Health Equity and Inclusion Insights Awarded "Best Healthcare Big Data Solution" in 8th Annual MedTech Breakthrough Awards Program
Relx PLC Executes Share Buyback Strategy